BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3409450)

  • 1. Potentiation of cis-diamminedichloroplatinum nephrotoxicity by amikacin in rats.
    Jongejan HT; Provoost AP; Molenaar JC
    Cancer Chemother Pharmacol; 1988; 22(2):178-80. PubMed ID: 3409450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiated nephrotoxicity of cisplatin when combined with amikacin comparing young and adult rats.
    Jongejan HT; Provoost AP; Molenaar JC
    Pediatr Nephrol; 1989 Jul; 3(3):290-5. PubMed ID: 2702108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the drug-induced nephrotoxicity by ATP-MgCl2. 1. Effects on the cis-diamminedichloroplatinum-treated isolated perfused kidneys.
    Sumpio BE; Chaudry IH; Baue AE
    J Surg Res; 1985 May; 38(5):429-37. PubMed ID: 3872963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cis-diamminedichloroplatinum and renal irradiation on renal function in the young and adult rat.
    Jongejan HT; van der Kogel AJ; Provoost AP; Molenaar JC
    Radiother Oncol; 1987 Sep; 10(1):49-57. PubMed ID: 3671772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity of aminoglycosides in young and adult rats.
    Provoost AP; Adejuyigbe O; Wolff ED
    Pediatr Res; 1985 Nov; 19(11):1191-6. PubMed ID: 4069829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma.
    Meijer S; Mulder NH; Sleijfer DT; de Jong PE; Sluiter WJ; Schraffordt Koops H; van der Hem GK
    Cancer Chemother Pharmacol; 1982; 8(1):27-30. PubMed ID: 7201356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat.
    Pirotzky E; Guilmard C; Sidoti C; Ivanow F; Principe P; Braquet P
    Ren Fail; 1990; 12(3):171-6. PubMed ID: 2287769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cisplatin-induced kidney injury using an integrated rodent platform.
    Chen Y; Brott D; Luo W; Gangl E; Kamendi H; Barthlow H; Lengel D; Fikes J; Kinter L; Valentin JP; Bialecki R
    Toxicol Appl Pharmacol; 2013 May; 268(3):352-61. PubMed ID: 23415679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
    Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
    Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function.
    Offerman JJ; Meijer S; Sleijfer DT; Mulder NH; Donker AJ; Koops HS; van der Hem GK
    Cancer Chemother Pharmacol; 1984; 12(1):36-8. PubMed ID: 6537801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.
    Meijer S; Mulder NH; Sleijfer DT; Donker AJ; Sluiter WJ; de Jong PE; Schraffordt Koops H; van der Hem GK
    Oncology; 1983; 40(3):170-3. PubMed ID: 6189040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity of acyclovir and cis-diamminedichloroplatinum(II)--effect of co-administration in rats.
    Hannemann J; Wunderle W; Baumann K
    J Cancer Res Clin Oncol; 1992; 118(3):181-6. PubMed ID: 1548282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion.
    Offerman JJ; Sleijfer DT; Mulder NH; Meijer S; Schraffordt Koops H; Donker AJ
    Cancer Chemother Pharmacol; 1985; 14(3):262-4. PubMed ID: 3888432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Nva2-cyclosporine on glomerular filtration rate and renal blood flow in the rat.
    Paller MS; Ferris TF
    Transplantation; 1987 Jun; 43(6):893-5. PubMed ID: 3590301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS; Riviere JE
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-methionine antagonism of cis-platinum nephrotoxicity.
    Basinger MA; Jones MM; Holscher MA
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):1-15. PubMed ID: 2315922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture.
    Tay LK; Bregman CL; Masters BA; Williams PD
    Cancer Res; 1988 May; 48(9):2538-43. PubMed ID: 2965614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased therapeutic effect on metastatic liver tumors in rats of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, with temporary clamping of the abdominal aorta.
    Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
    Cancer Chemother Pharmacol; 1990; 26(3):181-7. PubMed ID: 2357764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of CDDP assessed estimating glomerular filtration rate with 99mTc-DTPA plasma sample method.
    Fatima N; Niaz K; Maseeh-Uz-Zaman ; Kamal S; Hameed A
    J Coll Physicians Surg Pak; 2010 Feb; 20(2):98-101. PubMed ID: 20378036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular hemodynamics in cyclosporine nephrotoxicity following uninephrectomy.
    Winston JA; Feingold R; Safirstein R
    Kidney Int; 1989 May; 35(5):1175-82. PubMed ID: 2770102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.